ProLogium Technology Co., Ltd.: Mercedes-Benz and ProLogium have entered into a joint testing agreement, including a preliminary technology evaluation of ProLogium's latest Gen4 Superfluidized All Inorganic Solid State Battery Cell Technology
Mercedes-Benz and ProLogium have signed a joint testing agreement for ProLogium's Gen4 solid-state battery cells, building on a decade-long partnership. The agreement grants Mercedes-Benz priority access to test the technology, which offers high energy density, safety, and performance. ProLogium plans to go public on NASDAQ in 4Q2026 under the ticker PRLG.
How this was made
The 30-second read
Why it matters
The testing agreement could accelerate Mercedes' EV battery roadmap, while ProLogium's upcoming IPO may attract investor interest.
Market read
The deal signals deeper OEM‑battery maker collaboration, potentially influencing EV sector valuations and upcoming IPO sentiment.
What to watch
Regulatory approvals, scaling challenges, and competition from other solid‑state developers could limit impact.
Background
Mercedes-Benz has been pursuing solid‑state battery technology and has invested in ProLogium for years. ProLogium plans a Nasdaq listing in Q4 2026 under ticker PRLG.
Market effects
Strengthens the EV battery supply chain narrative, may boost broader EV and battery sector sentiment.
Highlights Taiwan's role in advanced battery tech, could benefit Asian battery manufacturers.
Shows major OEMs seeking solid‑state solutions, relevant to global EV rollout plans.
Counterpoint
The partnership may not translate into near‑term revenue, and battery commercialization risks remain high.
Key entities
- CompanyMercedes-Benz Group AG
German automotive OEM seeking advanced battery technologies.
- CompanyProLogium Holding Inc.
Taiwanese solid‑state battery developer planning a Nasdaq IPO.




